aspartic acid has been researched along with thromboplastin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, SW; Smith, KJ; Stafford, DW; Welsch, D | 1 |
| LeRoy, EC; Nossel, HL; Wilner, GD | 1 |
| Boys, CW; Edgington, TS; Kelly, CR; Martin, DM; Polikarpov, I; Ruf, W; Schullek, JR; Tuddenham, EG | 1 |
| Edgington, TS; Kelly, CR; Ruf, W; Schullek, JR | 1 |
| Bharadwaj, D; Foster, DC; Iino, M; Kisiel, W; Kontoyianni, M; Smith, KJ | 1 |
| Nielsen, LS; Olsen, OH; Ostergaard, A; Persson, E | 1 |
| Nielsen, LS; Olsen, OH; Persson, E | 1 |
| Dennis, MS; Eigenbrot, C; Kirchhofer, D; Lazarus, RA; Santell, L; Stamos, J; Ultsch, MH | 1 |
| Beck, DO; Kalafatis, M; Mann, KG | 1 |
| Grundy, JE; Lasia, B; Pryzdial, EL; Zeibdawi, AR | 1 |
| Bang, S; Bjelke, JR; Bolt, G; Fodje, M; Kragelund, BB; Olsen, OH; Persson, E; Svensson, LA | 1 |
| Collier, ME; Ettelaie, C | 1 |
12 other study(ies) available for aspartic acid and thromboplastin
| Article | Year |
|---|---|
Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.
Topics: 1-Carboxyglutamic Acid; Amino Acid Sequence; Animals; Aspartic Acid; Base Sequence; Blood Coagulation; Calcium; Cell Line; Epidermal Growth Factor; Factor IX; Factor VIIa; Factor X; Factor XIa; Gene Expression; Humans; Hydroxylation; Mice; Molecular Sequence Data; Recombinant Proteins; Thromboplastin | 1990 |
Activation of Hageman factor by collagen.
Topics: Adult; Aspartic Acid; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Viscosity; Calcium; Child; Collagen; Factor XII; Glutamates; Hot Temperature; Humans; Kaolin; Microbial Collagenase; Nitrobenzenes; Pepsin A; Skin; Sodium Chloride; Thromboplastin | 1968 |
Energetic contributions and topographical organization of ligand binding residues of tissue factor.
Topics: Aspartic Acid; Binding Sites; Extracellular Space; Factor VIIa; Humans; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Structure-Activity Relationship; Thromboplastin; Tryptophan | 1995 |
Tissue Factor residue Asp44 regulates catalytic function of the bound proteinase Factor VIIa.
Topics: Alanine; Animals; Aspartic Acid; Binding, Competitive; Catalysis; CHO Cells; Cricetinae; DNA; Factor VIIa; Humans; Kinetics; Mutation; Peptide Hydrolases; Solubility; Structure-Activity Relationship; Thromboplastin | 1996 |
Factor VII central. A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa, and abolishes amidolytic and coagulant activity.
Topics: Adult; Aspartic Acid; Blood Coagulation Disorders; Factor VII; Factor Xa; Humans; Hydrogen Bonding; Male; Models, Molecular; Point Mutation; Recombinant Proteins; Structure-Activity Relationship; Thromboplastin; Tyrosine | 1996 |
Ca2+ binding to the first epidermal growth factor-like domain of factor VIIa increases amidolytic activity and tissue factor affinity.
Topics: Aspartic Acid; Binding Sites; Calcium; Chromatography, Affinity; Epidermal Growth Factor; Factor VIIa; Factor X; Humans; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Protein Conformation; Thromboplastin | 1997 |
Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.
Topics: Allosteric Regulation; Amino Acid Substitution; Animals; Aspartic Acid; Binding Sites; Catalysis; Computer Simulation; Factor VIIa; Humans; Methionine; Models, Molecular; Mutagenesis, Site-Directed; Protein Binding; Rabbits; Recombinant Proteins; Solubility; Thromboplastin | 2001 |
The factor VII zymogen structure reveals reregistration of beta strands during activation.
Topics: Aspartic Acid; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Enzyme Precursors; Factor VII; Glutamic Acid; Isoleucine; Models, Molecular; Protein Conformation; Recombinant Proteins; Thromboplastin | 2001 |
Structural requirements for expression of factor Va activity.
Topics: Animals; Aspartic Acid; Binding Sites; Binding, Competitive; Catalysis; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Factor V; Factor Va; Factor VIIa; Humans; Kinetics; Mass Spectrometry; Peptides; Protein Binding; Protein C; Protein Structure, Tertiary; Snake Venoms; Thrombin; Thromboplastin; Time Factors | 2003 |
Coagulation factor Va Glu-96-Asp-111: a chelator-sensitive site involved in function and subunit association.
Topics: Amino Acid Sequence; Aspartic Acid; Binding Sites; Chelating Agents; Dimerization; Factor Va; Glutamic Acid; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Phospholipids; Protein Subunits; Thromboplastin | 2004 |
Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity.
Topics: Aspartic Acid; Calcium; Crystallography, X-Ray; Factor VIIa; Glutamic Acid; Humans; Hydrogen; Hydrogen Bonding; Models, Molecular; Mutation; Protein Binding; Protein Structure, Tertiary; Static Electricity; Thromboplastin; Time Factors | 2008 |
Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor.
Topics: Alanine; Apoptosis; Aspartic Acid; Blotting, Western; Cell-Derived Microparticles; Cells, Cultured; Humans; Oligopeptides; Phosphorylation; Serine; Signal Transduction; Thromboplastin | 2011 |